News - AB Science


Current filters:

AB Science

Popular Filters

AB Science files pancreatic cancer candidate masitinib with EMA


France-based AB Science SA (NYSE Euronext - FR0010557264 - AB) has confirmed the filing of a Marketing…

AB ScienceEuropemasitinibOncologyPharmaceuticalRegulation

AB Science leaps as GIST candidate masitinib beats Sutent


France-based AB Science (AB: EN Paris) saw its share price rocket as much as 72% to 10.60 euros after…

AB ScienceGastro-intestinalsmasitinibOncologyPfizerPharmaceuticalResearchSutent

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top